BeNEFIT: Bringing eHealth Nutrition Education to populations For Improved depression Treatment

Not Applicable

• Conditions: Major Depressive Disorder; Mental Health - Depression; Public Health - Health promotion/education

• Registration Number: ACTRN12622000693729
• Lead Sponsor: Deakin University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-13
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 672

Inclusion Criteria

Community-dwelling adults (age 18-65)
Depressive symptoms of at least mild severity (PHQ-8 greater than or equal to 5)
Access to internet and a smartphone or tablet
Ability to understand study materials and directions in English
Ability to download the mobile application from a respective app store
Ability to enter login details provided to access the mobile application
Agree not to enrol in another interventional clinical research trial while part of the study

Exclusion Criteria

Currently following a Mediterranean diet (greater than or equal to 11 on MEDAS at baseline) (Downer et al., 2016)
Individuals who are pregnant or breastfeeding, or who are intending to become pregnant
Individuals prescribed warfarin, heparin and other anti-coagulant medications
Individuals on immune-suppressing medication
Individuals receiving chemotherapy or radiotherapy
Individuals with a diagnosis of liver disease
Individuals with a diagnosis of kidney disease
Individuals with a diagnosed eating disorder
Individuals who have received medical advice to avoid vitamin, mineral or fish oil supplementation
Individuals who have commenced nutrient supplementation (vitamins, minerals, and/or fish oil) in the last month
Underweight (i.e. BMI less than 18.5)
Inability to follow Mediterranean diet study recommendations (i.e. currently vegan or paleo-style diet; inability to follow diet for sociocultural or religious reasons)
Diagnosed with or commenced new treatment for, anxiety and/or depression, within 1 month prior to baseline. Stable pharmacological or other therapy for more than one-month prior will not be an exclusion criterion.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in depressive symptoms, as measured by the 8-item Patient Health Questionnaire (PHQ-8)[Week 4 after baseline measures have been completed at point of consent.]